Abstract
Chronological measurements of various HCV markers were conducted to clarify the course and prognosis of acute hepatitis C. Among 49 patients with acute non-A, non-B hepatitis, 32 (65.3%) were diagnosed as having acute hepatitis C by these markers. Twenty-four (82.8%) of 29 patients with posttransfusion hepatitis were type C, while only eight (40.0%) of 20 patients with sporadic hepatitis were type C. Patients were also divided into those who returned to normal within one year based on changes in s-ALT levels and unresolved cases. Anti-HCV was present in 11 (44.4%) of 25 resolved cases and in 21 (87.1%) of 24 unresolved cases. Only one case was continuously positive for HCV-RNA although s-ALT levels returned to normal. In addition, quantitative determinations were conducted on those positive for anti-HCVs. Anti-second generation tested positive in all HCV-RNA-positive cases and positive rates were highest from the onset of hepatitis. In unresolved patients with continuous HCV infection, anti-core increased and titers at 12 months were 10 units or more in all cases. On the other hand, in eight of 10 resolved cases, titers declined gradually after initial seroconversion and titers were 10 units or less at 12 months. From these results, second generation anti-HCV was considered most useful in early diagnosis of acute hepatitis C and anti-core titer was considered most useful in predicting prognosis of acute hepatitis C.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kuo G, Choo Q-L, Alter HJ, et al: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364, 1989
Choo Q-L, Kuo G, Weiner AJ, et al: Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 244:359–362, 1989
Kato N, Hijikata M, Ootsuyama Y, et al: Molecular cloning of the human hepatitis C Virus Genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87:9524–9528, 1990
Takamizawa A, Mori C, Fuke I, et al: Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105–1113, 1991
Choo QL, Richman KH, Han JH, et al: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451–2455, 1991
Okamoto H, Okada S, Sugiyama Y, et al: Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol 72:2697–2704, 1991
Inchauspe G, Zebedee S, Lee DH, et al: Genomic structure of the human prototype strain H of hepatitis C: Comparison with American and Japanese isolates. Proc Natl Acad Sci USA 88:10292–10296, 1991
Han JH, Shyamala V, Richman KH, et al: Characterization of the terminal regions of hepatitis C viral RNA: Identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci USA 88:1711–1715, 1991
Mishiro S, Hoshi Y, Takeda K, et al: Non-A, non-B hepatitis specific antibodies directed at host-derived epitope-implication from an autoimmune prosess. Lancet 336:1400–1403, 1991
Arima T, Nagashima H, Murakami S, et al: Cloning of a cDNA associated with acute and chronic hepatitis C infection generated from patients serum RNA. Gastroenterol Jpn 24:540–544, 1989
Kanai K, Iwata K, Nakao K, et al: Diagnosis of non-A, non-B liver diseases using anti-N14 ELISA kit (Eiken Chemical kk) (in Japanese). J Med Pharm Sci 25:423–430, 1991
Okamoto H, Munekata E, Tuda F, et al: Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Jpn J Exp Med 60:223–233, 1990
Van der Poel CL, Cuypers HTM, Reesink HW, et al: Confirmation of hepatitis C Virus infection by new four-antigen recombinant immunoblot assay. Lancet 337:317–319, 1991
Iino S, Koike K, Yasuda K, et al: Study on second generation anti-HCV assay kit (HCV EIA II) (in Japanese). J Med Pharm Sci 25:87–95, 1991
Iino S, Koike K, Yasuda K, et al: Second generation anti-HCV assay system by passive hemagglutination (PHA) method (in Japanese). Prog Med 11:1911–1921, 1991
Garson JA, Tedder RS, Briggs M, et al: Detection of hepatitis C viral sequences in blood donations by “nested” polymerase chain reaction and prediction of infectivity. Lancet 336:1419–1422, 1990
Okamoto H, Okada S, Sugiyama Y, et al: Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-non-coding region. Jpn J Exp Med 60:215–222, 1990
Maeno M, Kaminaka K, Sugimoto H, et al: A cDNA clone closely associated with non-A, non-B hepatitis. Nucleic Acids Res 18:2685–2691, 1990
Takeuchi K, Kubo Y, Boonmar S, et al: The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol 71:3027–3033, 1990
Rakela J, Redeker AG: Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology 77:1200–1202, 1979
Berman M, Alter HJ, Ishak KG, et al: The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med 91:1–6, 1979
Seeff LB, Wright EC, Zimmerman HJ, et al: Post-transfusion hepatitis, 1973–1975: A Veterans Administration cooperative study.In viral Hepatitis. GN Vyas, SN Cohen, R Schmid (eds). Philadelphia, Franklin Institute Press, 1978, pp 371–382
Hino K, Kondo T, Niwa H, et al: A small epidemic of enterically transmitted non-A, non-B acute hepatitis. Gastroenterol Jpn 26 (suppl 3):139–141, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hino, K., Sainokami, S., Shimoda, K. et al. Clinical course of acute hepatitis C and changes in HCV markers. Digest Dis Sci 39, 19–27 (1994). https://doi.org/10.1007/BF02090055
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02090055